ALPHA TEKNOVA, INC. Operating Cash Flow
ALPHA TEKNOVA, INC. (TKNO) reported Operating Cash Flow of -$3.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$471.00K.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.36M.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$462.00K.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.98M.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$8.65M.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$12.39M.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$18.81M.
- ALPHA TEKNOVA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$27.40M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$471.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.83M 10-Q · filed 2026-08-06 | -$4.29M derived: sum of 3 quarters · filed 2026-08-06 | -$6.27M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$3.36M 10-Q · filed 2026-05-07 | -$3.82M derived: sum of 2 quarters · filed 2026-05-07 | -$5.80M derived: sum of 3 quarters · filed 2026-05-07 | -$7.90M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$2.44M derived: sum of 2 quarters · filed 2026-03-02 | -$4.54M derived: sum of 3 quarters · filed 2026-08-06 | -$8.65M 10-K · filed 2026-03-02 | |
| 2025-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.08M derived: sum of 2 quarters · filed 2026-08-06 | -$8.18M 10-Q · filed 2025-11-07 | -$9.12M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.20M 10-Q · filed 2026-08-06 | -$7.14M derived: sum of 3 quarters · filed 2026-08-06 | -$9.20M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$4.10M 10-Q · filed 2026-05-07 | -$5.04M derived: sum of 2 quarters · filed 2026-05-07 | -$7.10M derived: sum of 3 quarters · filed 2026-05-07 | -$9.94M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$936.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$3.00M derived: sum of 2 quarters · filed 2026-03-02 | -$5.83M derived: sum of 3 quarters · filed 2026-03-02 | -$12.39M 10-K · filed 2026-03-02 | |
| 2024-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.90M derived: sum of 2 quarters · filed 2025-11-07 | -$11.46M 10-Q · filed 2025-11-07 | -$14.35M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$9.40M 10-Q · filed 2025-08-08 | -$12.29M derived: sum of 3 quarters · filed 2025-08-08 | -$16.67M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$6.56M 10-Q · filed 2025-05-09 | -$9.45M derived: sum of 2 quarters · filed 2025-05-09 | -$13.83M derived: sum of 3 quarters · filed 2025-05-09 | -$17.69M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$7.27M derived: sum of 2 quarters · filed 2025-03-07 | -$11.13M derived: sum of 3 quarters · filed 2025-03-07 | -$18.81M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$8.24M derived: sum of 2 quarters · filed 2024-11-08 | -$15.92M 10-Q · filed 2024-11-08 | -$23.95M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$11.54M 10-Q · filed 2024-08-13 | -$19.57M derived: sum of 3 quarters · filed 2024-08-13 | -$27.90M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$7.68M 10-Q · filed 2024-05-13 | -$15.71M derived: sum of 2 quarters · filed 2024-05-13 | -$24.05M derived: sum of 3 quarters · filed 2024-05-13 | -$29.88M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$16.36M derived: sum of 2 quarters · filed 2024-03-27 | -$22.20M derived: sum of 3 quarters · filed 2024-03-27 | -$27.40M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$14.17M derived: sum of 2 quarters · filed 2023-11-13 | -$19.37M 10-Q · filed 2023-11-13 | -$22.45M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$5.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$11.04M 10-Q · filed 2023-08-11 | -$14.12M derived: sum of 3 quarters · filed 2023-08-11 | -$18.96M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$5.20M 10-Q · filed 2023-05-11 | -$8.28M derived: sum of 2 quarters · filed 2023-05-11 | -$13.12M derived: sum of 3 quarters · filed 2023-05-11 | -$16.67M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$7.92M derived: sum of 2 quarters · filed 2023-03-30 | -$11.47M derived: sum of 3 quarters · filed 2023-03-30 | -$9.07M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$4.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.39M derived: sum of 2 quarters · filed 2022-11-14 | -$5.99M 10-Q · filed 2022-11-14 | -$3.55M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.15M 10-Q · filed 2022-08-11 | $1.15M 10-Q · filed 2021-08-13 | $1.28M derived: sum of 3 quarters · filed 2022-08-11 | $3.05M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.40M 10-Q · filed 2022-05-12 | $4.83M derived: sum of 2 quarters · filed 2022-05-12 | $6.60M derived: sum of 3 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $4.20M derived: sum of 2 quarters · filed 2022-03-18 | $2.50M 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $71.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$1.70M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |